Cargando…

Extracellular Influences: Molecular Subclasses and the Microenvironment in Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) is the most prevalent form of pancreatic cancer and carries the worst prognosis of all common cancers. Five-year survival rates have not surpassed 6% for some decades and this lack of improvement in outcome urges a better understanding of the PDAC-specific fea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Veenstra, Veronique L., Garcia-Garijo, Andrea, van Laarhoven, Hanneke W., Bijlsma, Maarten F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836066/ https://www.ncbi.nlm.nih.gov/pubmed/29382042 http://dx.doi.org/10.3390/cancers10020034

Ejemplares similares

Stromal SPOCK1 supports invasive pancreatic cancer growth
por: Veenstra, Veronique L., et al.
Publicado: (2017)

The Cellular Origins of Cancer-Associated Fibroblasts and Their Opposing Contributions to Pancreatic Cancer Growth
por: Manoukian, Paul, et al.
Publicado: (2021)

Patched-2 functions to limit Patched-1 deficient skin cancer growth
por: Veenstra, Veronique L., et al.
Publicado: (2018)

Clinical Trials Targeting the Stroma in Pancreatic Cancer: A Systematic Review and Meta-Analysis
por: van Mackelenbergh, Madelaine G., et al.
Publicado: (2019)

Soluble Compounds Released by Hypoxic Stroma Confer Invasive Properties to Pancreatic Ductal Adenocarcinoma
por: Liu, Dajia, et al.
Publicado: (2020)

ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancreatic cancer
por: Kuninty, Praneeth R., et al.
Publicado: (2019)

The contributions of hypoxia to poor outcomes in pancreatic cancer
por: Bijlsma, Maarten F.
Publicado: (2022)

The case for a stratified application of targeted agents against pancreatic cancer
por: Bijlsma, Maarten F.
Publicado: (2021)

Proteomic analysis of gemcitabine-resistant pancreatic cancer cells reveals that microtubule-associated protein 2 upregulation associates with taxane treatment
por: Le Large, Tessa Ya Sung, et al.
Publicado: (2019)

Cancer Stem Cells, EMT, and Developmental Pathway Activation in Pancreatic Tumors
por: Hindriksen, Sanne, et al.
Publicado: (2012)

Unsupervised class discovery in pancreatic ductal adenocarcinoma reveals cell-intrinsic mesenchymal features and high concordance between existing classification systems
por: Dijk, Frederike, et al.
Publicado: (2020)

Genomic characterization of rare molecular subclasses of hepatocellular carcinoma
por: Damrauer, Jeffrey S., et al.
Publicado: (2021)

Molecular patterns identify distinct subclasses of myeloid neoplasia
por: Kewan, Tariq, et al.
Publicado: (2023)

The hepatic pre-metastatic niche in pancreatic ductal adenocarcinoma
por: Houg, Demi S., et al.
Publicado: (2018)

Tumor Immune Microenvironment Characterization in Hepatocellular Carcinoma Identifies Four Prognostic and Immunotherapeutically Relevant Subclasses
por: Gao, Xingxing, et al.
Publicado: (2021)

Influence of the bispecific antibody IgG subclass on T cell redirection
por: Kapelski, Stephanie, et al.
Publicado: (2019)

Cardiac molecular pathways influenced by doxorubicin treatment in mice
por: Bulten, Ben F., et al.
Publicado: (2019)

Impact of classical and basal-like molecular subtypes on overall survival in resected pancreatic cancer in the SPACIOUS-2 multicentre study
por: Suurmeijer, J Annelie, et al.
Publicado: (2022)

Peripheral T-cell lymphoma: molecular profiling recognizes subclasses and identifies prognostic markers
por: Rodríguez, Marta, et al.
Publicado: (2021)

Impact of IgG subclass on molecular properties of monoclonal antibodies
por: Tang, Yu, et al.
Publicado: (2021)

Association of hyperglycemia and molecular subclass on survival in IDH-wildtype glioblastoma
por: Liu, Elisa K, et al.
Publicado: (2022)

ADAM10-mediated release of heregulin confers resistance to trastuzumab by activating HER3
por: Ebbing, Eva A., et al.
Publicado: (2016)

Multidrug‐resistant transporter expression does not always result in drug resistance
por: Le Large, Tessa Ya Sung, et al.
Publicado: (2018)

Seed-in-Soil: Pancreatic Cancer Influenced by Tumor Microenvironment
por: Lin, Huey-Jen, et al.
Publicado: (2017)

LlpB represents a second subclass of lectin‐like bacteriocins
por: Ghequire, Maarten G. K., et al.
Publicado: (2019)

Molecular Characterization Reveals Subclasses of 1q Gain in Intermediate Risk Wilms Tumors
por: van Belzen, Ianthe A. E. M., et al.
Publicado: (2022)

Immunoglobulin G Subclass-Specific Glycosylation Changes in Primary Epithelial Ovarian Cancer
por: Wieczorek, Marta, et al.
Publicado: (2020)

Combined Expression of Plasma Thrombospondin‐2 and CA19‐9 for Diagnosis of Pancreatic Cancer and Distal Cholangiocarcinoma: A Proteome Approach
por: Le Large, Tessa Y.S., et al.
Publicado: (2020)

Editorial: Translational Insights Into Pancreatic Ductal Adenocarcinoma
por: Bijlsma, Maarten F., et al.
Publicado: (2022)

Subclassing and hooking with Visual Basic
por: Teilhet, Stephen
Publicado: (2001)

Subclass Changes in Fibrillary Glomerulonephritis
por: Biederman, Laura E., et al.
Publicado: (2022)

A novel diagnostic model for predicting immune microenvironment subclass based on costimulatory molecules in lung squamous carcinoma
por: Duan, Fangfang, et al.
Publicado: (2022)

Nationwide trends in chemotherapy use and survival of elderly patients with metastatic pancreatic cancer
por: van der Geest, Lydia G. M., et al.
Publicado: (2017)

Extracellular vesicle-mediated crosstalk between pancreatic cancer and stromal cells in the tumor microenvironment
por: Li, Ying, et al.
Publicado: (2022)

Specimen-specific drift of densities defines distinct subclasses of extracellular vesicles from human whole saliva
por: Yamamoto, Satoshi, et al.
Publicado: (2021)

Tumor Microenvironment: Extracellular Matrix Alterations Influence Tumor Progression
por: Brassart-Pasco, Sylvie, et al.
Publicado: (2020)

Acidic extracellular microenvironment and cancer
por: Kato, Yasumasa, et al.
Publicado: (2013)

ADAM12 is a circulating marker for stromal activation in pancreatic cancer and predicts response to chemotherapy
por: Veenstra, V. L., et al.
Publicado: (2018)

Influence of body composition and muscle strength on outcomes after multimodal oesophageal cancer treatment
por: Hagens, Eliza R.C., et al.
Publicado: (2020)

Immunoglobulin G1 Allotype Influences Antibody Subclass Distribution in Response to HIV gp140 Vaccination
por: Kratochvil, Sven, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_r14fa5rudh0s3j0t9gbjotct2g